IP Library Granted Patent US 7,131,997
Granted Patent B2
US 7,131,997 · App. 10/231,664 · Granted Nov 7, 2006

Tissue treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,131,997
App. No.
10/231,664
Granted
Nov 7, 2006
Kind
B2
Abstract

A method of treating tissue includes placing substantially spherical polymer particles in the tissue. The particles include an interior region having relatively large pores and a first region substantially surrounding the interior having fewer relatively large pores than the interior region.

Claims (40)

1. A method of treating tissue, the method comprising:

placing a plurality of substantially spherical polymer particles in the tissue, wherein:

the particles comprise first pores and second pores that are smaller than the first pores;

each particle has a center, a surface, a radius, a center region, and a surface region;

the center region extends radially from the center to about ⅓ of the radius;

the surface region extends radially from ⅔ of the radius to the surface; and

the surface region comprises fewer of the first pores than the center region.

2. The method of claim 1 , wherein the particles are injected into the tissue.

3. The method of claim 2 , wherein the particles are injected percutaneously.

4. The method of claim 1 , wherein the particles are delivered through a catheter.

5. The method of claim 1 , comprising forming a cavity in the tissue, and placing the particles in the cavity.

6. The method of claim 1 , wherein the tissue is adjacent to a body passageway.

7. The method of claim 6 , wherein the passageway is defined by a ureter.

8. The method of claim 1 , wherein the tissue is adjacent to a body passageway, the particles being placed in an amount effective to narrow the passageway.

9. The method of claim 1 , wherein the particles comprise polyvinyl alcohol.

10. The method of claim 9 , wherein the polyvinyl alcohol is 1,3 diol acetalized.

11. The method of claim 9 , wherein the particles comprise a polysaccharide.

12. The method of claim 9 , wherein the polysaccharide comprises alginate.

13. The method of claim 1 , wherein the particles comprise a therapeutic agent.

14. The method of claim 1 , wherein, for at least some of the plurality of particles, each particle has a different radius.

15. A method of treating an individual, the method comprising:

placing a therapeutically effective amount of substantially spherical particles comprising polyvinyl alcohol in a tissue of the individual,

wherein;

the particles comprise first pores and second pores that are smaller than the first pores;

each particle has a center, a surface, a radius, a center region, and a surface region;

the center region extends radially from the center to about ⅓ of the radius;

the surface region extends radially from ⅔ of the radius to the surface; and

the surface region comprises fewer of the first pores than the center region.

16. The method of claim 15 , further comprising selecting the individual diagnosed with gastroesophageal reflux disease.

17. The method of claim 16 , wherein the tissue is adjacent to a gastrointestinal tract.

18. The method of claim 15 , further comprising selecting the individual diagnosed with vesicoureteral reflux.

19. The method of claim 18 , wherein the tissue is adjacent to a ureter.

20. The method of claim 15 , further comprising selecting the individual diagnosed with urinary incontinence.

21. The method of claim 15 , further comprising selecting the individual diagnosed with fecal incontinence.

22. The method of claim 15 , wherein the particles are placed percutaneously.

23. The method of claim 15 , wherein the particles are placed through a catheter.

24. The method of claim 15 , further comprising selecting the individual diagnosed with instrinsic sphincteric deficiency.

25. The method of claim 15 , further comprising selecting the individual diagnosed with vocal cord paralysis.

26. The method of claim 15 , further comprising selecting the individual in need of a reconstructive or cosmetic procedure.

27. The method of claim 15 , wherein, for at least some of the therapeutically effective amount of particles, each particle has a different radius.

Assignments (2)
CHANGE OF NAME Recorded Nov 6, 2006
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018505/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2003
From: BOURNE, GEORGE; BUISER, MARCIA; CASEY II, THOMAS V.; KEENAN, STEVE; LANPHERE, JANEL; LI, JIANMIN; MCKENNA, ERIN; MINASIAN, ZAROUHI; RAO, DOREEN
To: SCIMED LIFE SYSTEMS, INC.
Reel/Frame 013693/0168 →